Technology

Adamis Pharmaceuticals

$0.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0282 (+3.63%) Today
+$0.005 (+0.62%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ADMP and other stocks, options, and ETFs commission-free!

About ADMP

Adamis Pharmaceuticals Corporation Common Stock, also called Adamis Pharmaceuticals, is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA. The listed name for ADMP is Adamis Pharmaceuticals Corporation Common Stock.

CEO
Dennis J. Carlo
Employees
171
Headquarters
San Diego, California
Founded
2006
Market Cap
72.61M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
11.79M
High Today
$0.837
Low Today
$0.7506
Open Price
$0.799
Volume
8.00M
52 Week High
$1.51
52 Week Low
$0.27

Collections

ADMP Earnings

-$0.16
-$0.11
-$0.05
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 30, After Hours

You May Also Like

EPWR=
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure